Clinical Trials Directory

Trials / Completed

CompletedNCT05998200

Safety of Serum for Post-Inflammatory on Hyperpigmentation Skin

Safety of Serum Containing Alpha Hydroxy Acid (AHA) and Polyglutamate Acid Derivatives for Post-Inflammatory on Hyperpigmentation Skin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
USMARI Research & Innovation Centre · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study aims to investigate the safety of serum product containing low dose of alpha hydroxy acid (AHA) i.e. 1% Glycolic acid and Lactic acid and Polyglutamate acid derivatives (PGA) for post-inflammatory hyperpigmentation skin in Malaysia. The study duration is 8 weeks and the skin assessment will be carried out at baseline, week 4 and week 8.The main questions this study aims to answer are: 1. To investigate the safety of serum containing low concentration AHA (1% Glycolic acid and Lactic acid) and PGA for post-inflammatory hyperpigmentation skin among Malaysian. 2. To assess the patient satisfaction after using serum containing low concentration AHA (1% Glycolic acid and Lactic acid) and PGA among Malaysian.

Conditions

Interventions

TypeNameDescription
OTHERSerum with low concentration AHA (1% Glycolic acid and Lactic acid) and PGAParticipants will used the serum twice daily for 8 weeks

Timeline

Start date
2023-07-01
Primary completion
2025-10-30
Completion
2025-10-30
First posted
2023-08-18
Last updated
2026-03-06

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT05998200. Inclusion in this directory is not an endorsement.